Arbutus Biopharma

ABUS

3.20

+0.05

+1.6%

After Hours:

3.20

0.00

0.0%

Stock Price
Open: 3.15
Prev. Close: 3.15
Low/Hi: 3.15 - 3.25
52-Week: 2.35 - 5.48
Volumes
Equity: 59,523
90-Day Avg: 306,478
Option: 85
90-Day Avg: 90
Volatility
Today: 30.4
20-Day: 60.5
52-Week: 65.7
30-Day IV: 45.6 -14.5
IV Rank: 0.04 (Subdued)
Fundamental
Div. Yield: 0.0%
Earnings: 22-Jun (Est.)
P/E Ratio:
Market Cap: 173.3 M
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ABUS Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Dec-2016 30-Sep-2016 30-Jun-2016 31-Mar-2016
Cash and Cash Equivalents 23,413 26,630 42,970 144,772
Short Term Investments 107,146 123,052 122,340 27,802
Investments - - - -
Accounts Receivable 694 671 732 714
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 1,311 1,459 2,043 1,469
Net Property Plant and Equipment 6,945 4,086 3,944 3,242
Other Current Assets 0 0 0 0
Current Assets 132,564 151,812 168,085 174,757
Goodwill and Intangibles 123,809 358,832 358,832 515,156
Long Term Investments 0 0 0 10,099
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 275,919 514,730 530,861 703,254
Short Term Debt 0 0 0 0
Other Non-Current Assets 12,601 0 0 0
Accounts Payable 9,910 7,132 7,753 7,711
Accrued Liabilities and Other Payables 0 0 0 0
Long Term Debt 12,001 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 72,914 98,105 99,537 165,177
Other Current Liabilities 675 1,260 2,331 3,401
Accumulated Other Comprehensive Income -49,782 -49,782 -49,782 -49,782
Preferred Stock 0 0 0 0
Current Liabilities 10,585 8,392 10,084 11,112
Common Stock 867,393 864,375 861,148 840,475
Other Non-Current Liabilities 50,328 89,713 89,453 154,065
Additional Paid-In Capital 36,543 34,486 32,817 30,243
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -651,149 -432,454 -412,859 -282,859
Total Equity 203,005 416,625 431,324 538,077
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 23,413 166,779 72,187 68,717
Short Term Investments 107,146 14,525 39,974 0
Investments - - - -
Accounts Receivable 694 1,382 2,527 369
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 1,311 1,196 1,730 1,084
Net Property Plant and Equipment 6,945 3,183 1,760 1,373
Other Current Assets 0 0 0 173
Current Assets 132,564 183,882 116,418 70,343
Goodwill and Intangibles 123,809 515,156 0 0
Long Term Investments 0 10,070 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 275,919 712,291 118,178 71,716
Short Term Debt 0 0 0 0
Other Non-Current Assets 12,601 0 0 0
Accounts Payable 9,910 8,827 9,328 3,680
Accrued Liabilities and Other Payables 0 0 0 0
Long Term Debt 12,001 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 72,914 164,612 30,143 12,522
Other Current Liabilities 675 1,751 10,878 8,842
Accumulated Other Comprehensive Income -49,782 -49,782 -22,313 -15,825
Preferred Stock 0 0 0 0
Current Liabilities 10,585 10,578 20,206 12,522
Common Stock 867,393 834,240 290,004 216,702
Other Non-Current Liabilities 50,328 154,034 9,937 0
Additional Paid-In Capital 36,543 30,206 26,208 25,343
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -651,149 -266,985 -205,864 -167,027
Total Equity 203,005 547,679 88,035 59,193